Connexin36 contributes to INS-1E cells survival through modulation of cytokine-induced oxidative stress, ER stress and AMPK activity

Cell Death and Differentiation

Volumn 20, Issue 12, 2013, Pages 1742-1752

  Allagnat, F ^a   Klee, P ^b   Cardozo, A K ^c   Meda, P ^b   Haefliger, J A ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

AMPK; apoptosis; Connexin36; cytokines; Gap junctions; pancreatic beta cells

Indexed keywords

ADENOVIRUS VECTOR; CONNEXIN 36; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1BETA; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CALCIUM HOMEOSTASIS; CANCER CELL CULTURE; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE INDUCED OXIDATIVE STRESS; DEGRADATION; DEPLETION; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; INSULINOMA CELL LINE; MODULATION; MOUSE; NONHUMAN; OXIDATIVE STRESS; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; APOPTOSIS; CALCIUM; CASPASE 3; CELL SURVIVAL; CONNEXINS; CYCLIC AMP; CYTOKINES; DOWN-REGULATION; ENDOPLASMIC RETICULUM STRESS; FEEDBACK, PHYSIOLOGICAL; HUMANS; INSULIN; INSULIN-SECRETING CELLS; INTERLEUKIN-1BETA; METFORMIN; MICE; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDATIVE STRESS; RATS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC;

EID: 84887620071     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2013.134     Document Type: Article

References (52)

1. Bosco D, Haefliger JA, Meda P. Connexins: Key mediators of endocrine function. Physiol Rev 2011; 91: 1393-1445.
2. Cigliola V, Chellakudam V, Arabieter W, Meda P. Connexins and beta-cell functions. Diabetes Res Clin Pract 2013; 99: 250-259.
3. Decrock E, Vinken M, De Vuyst E, Krysko DV, DHerde K, Vanhaecke T et al. Connexinrelated signaling in cell death: To live or let die Cell Death Differ 2009; 16: 524-536.
4. Klee P, Allagnat F, Pontes H, Cederroth M, Charollais A, Caille D et al. Connexins protect mouse pancreatic beta cells against apoptosis. J Clin Invest 2011; 121: 4870-4879.
5. Eizirik DL, Colli ML, Ortis F. The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol 2009; 5: 219-226.
6. Thomas HE, McKenzie MD, Angstetra E, Campbell PD, Kay TW. Beta cell apoptosis in diabetes. Apoptosis 2009; 14: 1389-1404.
7. Robertson RP. Beta-cell deterioration during diabetes: Whats in the gun Trends Endocrinol Metab 2009; 20: 388-393.
8. Gurzov EN, Eizirik DL. Bcl-2 proteins in diabetes: Mitochondrial pathways of beta-cell death and dysfunction. Trends Cell Biol 2011; 21: 424-431.
9. Youle RJ, Strasser A. The BCL-2 protein family: Opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008; 9: 47-59.
10. Rasola A, Bernardi P. Mitochondrial permeability transition in Ca(2)-dependent apoptosis and necrosis. Cell Calcium 2011; 50: 222-233.
11. Rizzuto R, De Stefani D, Raffaello A, Mammucari C. Mitochondria as sensors and regulators of calcium signalling. Nat Rev Mol Cell Biol 2012; 13: 566-578.
12. Allagnat F, Fukaya M, Nogueira TC, Delaroche D, Welsh N, Marselli L et al. C/EBP homologous protein contributes to cytokine-induced pro-inflammatory responses and apoptosis in beta-cells. Cell Death Differ 2012; 19: 1836-1846.
13. Hardie DG, Ross FA, Hawley SA. AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat Rev Mol Cell Biol 2012; 13: 251-262.
14. Scorrano L. Opening the doors to cytochrome c: Changes in mitochondrial shape and apoptosis. Int J Biochem Cell Biol 2009; 41: 1875-1883.
15. Cardozo AK, Ortis F, Storling J, Feng YM, Rasschaert J, Tonnesen M et al. Cytokines downregulate the sarcoendoplasmic reticulum pump Ca2 ATPase 2b and deplete endoplasmic reticulum Ca2, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes 2005; 54: 452-461.
16. Allagnat F, Cunha D, Moore F, Vanderwinden JM, Eizirik DL, Cardozo AK. Mcl-1 downregulation by pro-inflammatory cytokines and palmitate is an early event contributing to beta-cell apoptosis. Cell Death Differ 2011; 18: 328-337.
17. Lemmens R, Larsson O, Berggren PO, Islam MS. Ca2-induced Ca2 release from the endoplasmic reticulum amplifies the Ca2 signal mediated by activation of voltage-gated L-type Ca2 channels in pancreatic beta-cells. J Biol Chem 2001; 276: 9971-9977.
18. Chen L, Koh DS, Hille B. Dynamics of calcium clearance in mouse pancreatic beta-cells. Diabetes 2003; 52: 1723-1731. (Pubitemid 36792463)
19. Fogarty S, Hawley SA, Green KA, Saner N, Mustard KJ, Hardie DG. Calmodulindependent protein kinase kinase-beta activates AMPK without forming a stable complex: Synergistic effects of Ca2 and AMP. Biochem J 2010; 426: 109-118.
20. Tokumitsu H, Inuzuka H, Ishikawa Y, Ikeda M, Saji I, Kobayashi R. STO-609 a specific inhibitor of the Ca(2)/calmodulin-dependent protein kinase kinase. J Biol Chem 2002; 277: 15813-15818. (Pubitemid 34967859)
21. Allagnat F, Alonso F, Martin D, Abderrahmani A, Waeber G, Haefliger JA. ICER-1gamma overexpression drives palmitate-mediated connexin36 down-regulation in insulin-secreting cells. J Biol Chem 2008; 283: 5226-5234.
22. Haefliger JA, Martin D, Favre D, Petremand J, Mazzolai L, Abderrahmani A et al. Reduction of Connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particles. PLoS One 2013; 8: E55198.
23. Lee JM, Seo WY, Song KH, Chanda D, Kim YD, Kim DK et al. AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner. J Biol Chem 2010; 285: 32182-32191.
24. Fu A, Screaton RA. Using kinomics to delineate signaling pathways: Control of CRTC2/ TORC2 by the AMPK family. Cell Cycle 2008; 7: 3823-3828.
25. Haefliger JA, Martin D, Favre D, Petremand Y, Mazzolai L, Abderrahmani A et al. Reduction of connexin36 content by ICER-1 contributes to insulin-secreting cells apoptosis induced by oxidized LDL particles. PLoS One 2013; 8: E55198.
26. Riboulet-Chavey A, Diraison F, Siew LK, Wong FS, Rutter GA. Inhibition of AMP-activated protein kinase protects pancreatic beta-cells from cytokine-mediated apoptosis and CD8 T-cell-induced cytotoxicity. Diabetes 2008; 57: 415-423.
27. Ollila S, Makela TP. The tumor suppressor kinase LKB1: Lessons from mouse models. J Mol Cell Biol 2011; 3: 330-340.
28. Lizcano JM, Goransson O, Toth R, Deak M, Morrice NA, Boudeau J et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. Embo J 2004; 23: 833-843. (Pubitemid 38418750)
29. Hawley SA, Boudeau J, Reid JL, Mustard KJ, Udd L, Makela TP et al. Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol 2003; 2: 28.
30. Woods A, Dickerson K, Heath R, Hong SP, Momcilovic M, Johnstone SR et al. Ca2/ calmodulin-dependent protein kinase kinase-beta acts upstream of AMP-activated protein kinase in mammalian cells. Cell Metab 2005; 2: 21-33. (Pubitemid 43239822)
31. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM et al. Calmodulindependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2005; 2: 9-19. (Pubitemid 43239821)
32. da Silva Xavier G, Leclerc I, Salt IP, Doiron B, Hardie DG, Kahn A et al. Role of AMPactivated protein kinase in the regulation by glucose of islet beta cell gene expression. Proc Natl Acad Sci USA 2000; 97: 4023-4028. (Pubitemid 30226080)
33. Woods A, Salt I, Scott J, Hardie DG, Carling D. The alpha1 and alpha2 isoforms of the AMP-activated protein kinase have similar activities in rat liver but exhibit differences in substrate specificity in vitro. FEBS Lett 1996; 397: 347-351. (Pubitemid 26414047)
34. Klaus A, Polge C, Zorman S, Auchli Y, Brunisholz R, Schlattner U. A two-dimensional screen for AMPK substrates identifies tumor suppressor fumarate hydratase as a preferential AMPKalpha2 substrate. J Proteomics 2012; 75: 3304-3313.
35. Witczak CA, Sharoff CG, Goodyear LJ. AMP-activated protein kinase in skeletal muscle: From structure and localization to its role as a master regulator of cellular metabolism. Cell Mol Life Sci 2008; 65: 3737-3755.
36. Allagnat F, Martin D, Condorelli DF, Waeber G, Haefliger JA. Glucose represses connexin36 in insulin-secreting cells. J Cell Sci 2005; 118(Pt 22): 5335-5344. (Pubitemid 41819595)
37. Kefas BA, Cai Y, Kerckhofs K, Ling Z, Martens G, Heimberg H et al. Metformininduced stimulation of AMP-activated protein kinase in beta-cells impairs their glucose responsiveness and can lead to apoptosis. Biochem Pharmacol 2004; 68: 409-416. (Pubitemid 38887423)
38. Kefas BA, Cai Y, Ling Z, Heimberg H, Hue L, Pipeleers D et al. AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J Mol Endocrinol 2003; 30: 151-161. (Pubitemid 36592509)
39. Cai Y, Wang Q, Ling Z, Pipeleers D, McDermott P, Pende M et al. Akt activation protects pancreatic beta cells from AMPK-mediated death through stimulation of mTOR. Biochem Pharmacol 2008; 75: 1981-1993.
40. Pinton P, Giorgi C, Siviero R, Zecchini E, Rizzuto R. Calcium and apoptosis: ER-mitochondria Ca2 transfer in the control of apoptosis. Oncogene 2008; 27: 6407-6418.
41. Ahn YJ, Kim H, Lim H, Lee M, Kang Y, Moon S et al. AMP-activated protein kinase: Implications on ischemic diseases. BMB Rep 2012; 45: 489-495.
42. Ravier MA, Guldenagel M, Charollais A, Gjinovci A, Caille D, Sohl G et al. Loss of connexin36 channels alters beta-cell coupling, islet synchronization of glucoseinduced Ca2 and insulin oscillations, and basal insulin release. Diabetes 2005; 54: 1798-1807. (Pubitemid 40770770)
43. Bavamian S, Pontes H, Cancela J, Charollais A, Startchik S, Van De Ville D et al. The intercellular synchronization of Ca2 oscillations evaluates Cx36-dependent coupling. PLoS One 2012; 7: E41535.
44. Head WS, Orseth ML, Nunemaker CS, Satin LS, Piston DW, Benninger RK. Connexin-36 gap junctions regulate in vivo first-and second-phase insulin secretion dynamics and glucose tolerance in the conscious mouse. Diabetes 2012; 61: 1700-1707.
45. Benninger RK, Zhang M, Head WS, Satin LS, Piston DW. Gap junction coupling and calcium waves in the pancreatic islet. Biophys J 2008; 95: 5048-5061.
46. Tengholm A, Gylfe E. Oscillatory control of insulin secretion. Mol Cell Endocrinol 2009; 297: 58-72.
47. Decrock E, Krysko DV, Vinken M, Kaczmarek A, Crispino G, Bol M et al. Transfer of IP(3) through gap junctions is critical, but not sufficient, for the spread of apoptosis. Cell Death Differ 2012; 19: 947-957.
48. McCullough LD, Zeng Z, Li H, Landree LE, McFadden J, Ronnett GV. Pharmacological inhibition of AMP-activated protein kinase provides neuroprotection in stroke. J Biol Chem 2005; 280: 20493-20502. (Pubitemid 40776749)
49. Yen JC, Chang FJ, Chang S. A new criterion for automatic multilevel thresholding. IEEE Trans Image Proc 1995; 4: 370-378.
50. Moore AF, Jablonski KA, Mason CC, McAteer JB, Arakaki RF, Goldstein BJ et al. The association of ENPP1 K121Q with diabetes incidence is abolished by lifestyle modification in the diabetes prevention program. J Clin Endocrinol Metab 2009; 94: 449-455.
51. Foretz M, Ancellin N, Andreelli F, Saintillan Y, Grondin P, Kahn A et al. Short-term overexpression of a constitutively active form of AMP-activated protein kinase in the liver leads to mild hypoglycemia and fatty liver. Diabetes 2005; 54: 1331-1339. (Pubitemid 40586661)
52. Allagnat F, Christulia F, Ortis F, Pirot P, Lortz S, Lenzen S et al. Sustained production of spliced X-box binding protein 1 (XBP1) induces pancreatic beta cell dysfunction and apoptosis. Diabetologia 2010; 53: 1120-1130.